Explore
Search ClinicalTrials.gov
Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.
Results for “Germany”
Sponsor: Gubra A/S
Obesity · Type 2 Diabetes
Germany
- Pan Tumor Rollover StudyRecruiting
Sponsor: Bristol-Myers Squibb
Cancer
United States, Argentina, Australia, Austria, Belgium +33 more
- Continuous or Intermittent Cetuximab Plus FOLFIRI as First-line Treatment in RAS/BRAF Wild-type mCRC PatientsNot Yet Recruiting
Sponsor: Charite University, Berlin, Germany
Colorectal Cancer Metastatic
Germany
- A Study to Evaluate the Efficacy and Safety of Sotagliflozin in Symptomatic Obstructive and Non-obstructive Hypertrophic CardiomyopathyActive Not Recruiting
Sponsor: Lexicon Pharmaceuticals
Obstructive Cardiomyopathy, Hypertrophic · Non-obstructive Hypertrophic Cardiomyopathy
United States, Argentina, Belgium, Brazil, Bulgaria +14 more
- A Study to Learn About How Safe Nitroglycerin is and How it Affects the Body When Taken Along With Nurandociguat in People With Coronary Artery DiseaseNot Yet Recruiting
Sponsor: Bayer
Stable Coronary Artery Disease
Bulgaria, Germany
Sponsor: Novartis Pharmaceuticals
Generalized Myasthenia Gravis
United States, Argentina, Australia, Belgium, Brazil +15 more
- A Non-interventional Cohort Safety Study of Patients With hATTR-PNActive Not Recruiting
Sponsor: Akcea Therapeutics
Hereditary Transthyretin Amyloidosis With Polyneuropthy
Bulgaria, Cyprus, France, Germany, Greece +3 more
Sponsor: GlaxoSmithKline
Neoplasms, Lung
Argentina, Australia, Brazil, Bulgaria, Canada +19 more
Sponsor: AstraZeneca
Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)
Germany
Sponsor: Sanofi
Chronic Inflammatory Demyelinating Polyneuropathy
United States, Argentina, Belgium, Brazil, Canada +18 more
Sponsor: Charite University, Berlin, Germany
Melanoma (Skin Cancer)
Germany
- A Study to Evaluate the Efficacy of NIO752 in Participants With Progressive Supranuclear PalsyRecruiting
Sponsor: Novartis Pharmaceuticals
Progressive Supranuclear Palsy Richardson Syndrome (PSP-RS)
United States, Australia, China, France, Germany +5 more
- Durvalumab With Chemotherapy as First Line Treatment in Patients With Advanced Biliary Tract Cancers (aBTCs)Active Not Recruiting
Sponsor: AstraZeneca
Biliary Tract Cancer
United States, France, Germany, Italy, Japan +3 more
Sponsor: Merck Sharp & Dohme LLC
Non-small Cell Lung Cancer
United States, Argentina, Australia, Belgium, Brazil +20 more
- Study of XL092 + Nivolumab vs Sunitinib in Subjects With Advanced or Metastatic Non-Clear Cell Renal Cell CarcinomaActive Not Recruiting
Sponsor: Exelixis
Non-Clear Cell Renal Cell Carcinoma
United States, Argentina, Australia, Brazil, Bulgaria +20 more
Sponsor: Bristol-Myers Squibb
Alzheimer's Disease
United States, Argentina, Chile, Czechia, France +9 more
Sponsor: University Heart Center Freiburg - Bad Krozingen
Cardiogenic Shock · Acute Heart Failure (AHF)
Germany
Sponsor: EMD Serono Research & Development Institute, Inc.
Central Nervous System Tumors
Canada, France, Germany, South Korea
Sponsor: Bristol-Myers Squibb
Urothelial Cancer
United States, Argentina, Australia, Austria, Belgium +17 more
Sponsor: Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
Lymphoma
United States, France, Germany
- Olaparib Treatment in BRCA Mutated Ovarian Cancer Patients After Complete or Partial Response to Platinum ChemotherapyActive Not Recruiting
Sponsor: AstraZeneca
Platinum Sensitive · BRCA Mutated · Relapsed Ovarian Cancer · Following Complete or Partial Response to Platinum Based Chemotherapy
United States, Australia, Belgium, Brazil, Canada +12 more
- Study of Volrustomig in Women With High Risk Locally Advanced Cervical Cancer (eVOLVE-Cervical)Recruiting
Sponsor: AstraZeneca
Locally Advanced Cervical Cancer
United States, Brazil, Canada, China, Denmark +14 more
Sponsor: Crinetics Pharmaceuticals Inc.
Acromegaly
United States, Brazil, Germany, Greece, Hungary +2 more
Sponsor: Assistance Publique - Hôpitaux de Paris
Decompensated Liver Cirrhosis · Primary Biliary Cholangitis · Primary Sclerosing Cholangitis · Hepato-cellular Carcinoma
Austria, Belgium, France, Germany, Italy +2 more
- A Study of Orforglipron (LY3502970) in Participants With Obesity or Overweight and at Least One Weight-Related ComorbidityActive Not Recruiting
Sponsor: Eli Lilly and Company
Obesity · Overweight
United States, Argentina, China, Czechia, Germany +2 more